Macquarie Group

Macquarie Group’s Ocular Therapeutix OCUL Stock Holding History

Macquarie Group’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-174,389	Closed	-$2.04M	–	1293
2025 Q3	$2.04M	Sell	174,389 -67,650	-28%	-$809K	﹤0.01%	1164
2025 Q2	$2.25M	Sell	242,039 -2,945	-1%	-$23.1K	﹤0.01%	1186
2025 Q1	$1.8M	Buy	244,984 +234,436	+2,223%	+$1.8M	﹤0.01%	1255
2024 Q4	$90	Buy	+10,548	New	+$103K	﹤0.01%	1628
2022 Q2	–	Sell	-8,837	Closed	-$44	–	2607
2022 Q1	$44	Hold	8,837	–	–	﹤0.01%	2182
2021 Q4	$62K	Sell	8,837 -2,149	-20%	-$16.7K	﹤0.01%	2084
2021 Q3	$110K	Buy	10,986 +7,396	+206%	+$83.1K	﹤0.01%	1954
2021 Q2	$51K	Buy	3,590 +2,406	+203%	+$36.6K	﹤0.01%	2155
2021 Q1	$19K	Sell	1,184 -562	-32%	-$10.8K	﹤0.01%	2296
2020 Q4	$36K	Buy	+1,746	New	+$25.9K	﹤0.01%	2112
2018 Q1	–	Sell	-6,900	Closed	-$31K	–	2311
2017 Q4	$31K	Buy	+6,900	New	+$35.2K	﹤0.01%	2141

Other funds holding OCUL

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return